Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions

Microbial proteins have recently been found to have more benefits in clinical disease treatment because of their better-developed strategy and properties than traditional medicine. In this study, we investigated the effectiveness of a truncated peptide synthesized from the C-terminal sequence of pne...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Shun-Fu, Chen, Cheng-Nan, Lin, Jung-Chung, Wang, Hsin-Ell, Mori, Shigetarou, Li, Jia-Je, Yen, Chia-Kuang, Hsu, Ching-Yun, Fung, Chang-Phone, Chong, Pele Choi-Sing, Leng, Chih-Hsiang, Ding, Yi-Jun, Chang, Feng-Yee, Siu, L. Kristopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290803/
https://www.ncbi.nlm.nih.gov/pubmed/32397494
http://dx.doi.org/10.3390/cells9051183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290803/
https://www.ncbi.nlm.nih.gov/pubmed/32397494
http://dx.doi.org/10.3390/cells9051183

Ejemplares similares